Popoli et al27 think that the selective A2AR antagonist CSC has a neuroprotective effect during the first 15 minutes after cerebral ischemia in rats, but this effect will disappear after 2 weeks of continuous treatment with the same dose of CSC. The gene discussed is ADORA2A; the disease is Cerebral ischemia.